Literature DB >> 27612879

Lipoprotein profiles of hepatic cell lines at various stages of differentiation.

Akira Sasaki1,2, Fumiko Kimura3, Mizuho Miura3, Gen Toshima3, Junichiro Takahashi3, Sayuri Maruya4, Masayuki Kobayashi5, Keishi Hata6.   

Abstract

We studied the lipoprotein profiles of human hepatic cells at various stages of differentiation. The production of three major classes of lipoproteins, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL), was detected in three well-differentiated human hepatoma cell lines and primary human hepatocytes; however, these lipoproteins were not detected in the culture medium in which undifferentiated hepatoma cell lines were grown. Reverse transcription polymerase chain reaction analysis demonstrated that the expression levels of apolipoprotein A1 (ApoA1), ApoB100, and microsomal triglyceride transfer protein (MTP) were markedly lower in the undifferentiated hepatoma cell lines than in the well-differentiated hepatoma cell lines and primary hepatocytes. These results indicate that apolipoprotein synthesis, and triglyceride-transport by MTP might be rate-limiting steps in lipoprotein production in mature hepatic cells.

Entities:  

Keywords:  Apolipoprotein; Hepatic cell differentiation; Lipoprotein

Mesh:

Substances:

Year:  2016        PMID: 27612879     DOI: 10.1007/s11626-016-0091-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  9 in total

1.  Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction.

Authors:  Kazuo Takayama; Mitsuru Inamura; Kenji Kawabata; Michiko Sugawara; Kiyomi Kikuchi; Maiko Higuchi; Yasuhito Nagamoto; Hitoshi Watanabe; Katsuhisa Tashiro; Fuminori Sakurai; Takao Hayakawa; Miho Kusuda Furue; Hiroyuki Mizuguchi
Journal:  J Hepatol       Date:  2012-05-29       Impact factor: 25.083

2.  Efficient differentiation of functional hepatocytes from human embryonic stem cells.

Authors:  Sadhana Agarwal; Katherine L Holton; Robert Lanza
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

3.  Advantages of assessing lipoprotein profiles in hepatic cell differentiation.

Authors:  Junichiro Takahashi; Fumiko Kimura; Mizuho Miura; Yuka Iwama; Gen Toshima; Keishi Hata
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

4.  Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells.

Authors:  Karim Si-Tayeb; Fallon K Noto; Masato Nagaoka; Jixuan Li; Michele A Battle; Christine Duris; Paula E North; Stephen Dalton; Stephen A Duncan
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

5.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.

Authors:  D P Aden; A Fogel; S Plotkin; I Damjanov; B B Knowles
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

6.  Infection of a human hepatoma cell line by hepatitis B virus.

Authors:  Philippe Gripon; Sylvie Rumin; Stephan Urban; Jacques Le Seyec; Denise Glaise; Isabelle Cannie; Claire Guyomard; Josette Lucas; Christian Trepo; Christiane Guguen-Guillouzo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

7.  Establishment and some biological characteristics of human hepatoma cell lines.

Authors:  I Dor; M Namba; J Sato
Journal:  Gan       Date:  1975-08

8.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

9.  HPLC analysis of lipoproteins in culture medium of hepatoma cells: an in vitro system for screening antihyperlipidemic drugs.

Authors:  Mizuho Itoh; Yukie Abe; Yuka Iwama; Fumiko Kimura; Mayumi Satoh; Mayumi Shoji; Junichiro Takahashi; Gen Toshima; Hiroki Sasaki; Kazuyuki Hiwatashi; Keishi Hata
Journal:  Biotechnol Lett       Date:  2009-03-29       Impact factor: 2.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.